Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • No Clinical trials on...

    No Clinical trials on humans for proven drugs: New Proposal

    Written by Ruby Khatun Khatun Published On 2017-08-08T10:00:37+05:30  |  Updated On 8 Aug 2017 10:00 AM IST
    No Clinical trials on humans for proven drugs: New Proposal

    New Delhi: In order to make new drugs available for critical diseases and to reduce their costs in Indian market, health ministry is planning to waive off clinical trials on humans for proven drugs, which have been already approved in developed markets like the US, European Union, Japan, Canada and Australia for at least two years .


    Currently, legal provisions require successful local clinical trials, before these drugs are introduced in the Indian Market. Moreover, waivers are given by the drug regulator, but they are analysed on case to case basis.


    However, the Health Ministry is now planning to a policy change in order to do away with local clinical trials for drugs which have a already proven themselves in the international market and have a record of not affecting patients severely.


    The draft set of rules has been forwarded by the Health Ministry to the law ministry for vetting. The same shall be notified after the law ministry's nod, reports Mint


    Drugs Controller General of India GN Singh told TOI "the recommendations were made by the Ranjit Roy Chowdhary committee some time back. The idea is to take a progressive step in the direction of making essential and innovative medicines available in India at a fast pace."


    This step is directed towards stopping many meaningless trials and making available new drugs to the Indian public. Companies, however, will also be required to do post marketing trials and submit data in a specified period after the launch.


    “Our primary objective is to ascertain safety and efficacy of the drug in Indian patients. Hence, we will still decide on case to case basis and take a call depending on the need and efficacy of the drug,” Singh said.


    clinical trialscritical diseasesDrugController General of IndiaGN SinghHealth MinistryhumansIndian marketmedicinesnewNo Clinical trialsProposalproven drugsRanjit Roy Chowdharywaive off
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok